What lessons have been learnt from animal models of MRSA in the lung?

European Respiratory Journal

Volumn 35, Issue 1, 2010, Pages 198-201

  Martinez Olondris P ^a   Rigol, M ^a   Torres, A ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Animal model; Lung; Methicillin resistant staphylococcus aureus

Indexed keywords

7 [3 (1 AMINOCYCLOPROPYL) 1 PYRROLIDINYL] 1 (2 FLUOROCYCLOPROPYL) 1,4 DIHYDRO 8 METHOXY 4 OXO 3 QUINOLINECARBOXYLIC ACID; ANTIINFECTIVE AGENT; CYCLOPHOSPHAMIDE; DALFOPRISTIN; DALFOPRISTIN PLUS QUINUPRISTIN; DQ 113; FORMALDEHYDE; LINEZOLID; MIKAMYCIN B; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SMALL INTERFERING RNA; TEICOPLANIN; TELAVANCIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; AREA UNDER THE CURVE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PHARMACOLOGICAL PARAMETERS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; STAPHYLOCOCCAL PNEUMONIA; SURVIVAL RATE;

ANIMALS; DISEASE MODELS, ANIMAL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PNEUMONIA, BACTERIAL;

EID: 75149127810     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00113908     Document Type: Review

References (25)

1. Fluckiger U, Widmer AF. Epidemiology of methicillin-resistant Staphylococcus aureus. Chemotherapy 1999; 45: 121-134.
2. National Nosocomial Infections Surveillance (NNIS) System report, data summary from October 1986 through April 1998. Atlanta, Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1998.
3. Kollef MH, Morrow LE, Niederman MS, et al. Clinical characteristics and treatment patterns among patients with ventilatorassociated pneumonia. Chest 2006; 129: 1210-1218.
4. Maranan MC, Moreira B, Boyle-Vavra S, et al. Antimicrobial resistance in staphylococci: epidemiology, molecular mechanisms, and clinical relevance. Infect Dis Clin North Am 1997; 11: 813-849.
5. Panlilio AL, Culver DH, Gaynes RP, et al. Methicillin-resistant Staphylococcus aureus in US hospitals, 1975-1991. Infect Control Hosp Epidemiol 1992; 13: 582-586.
6. Voss A, Milatovic D, Wallrauch-Schwarz C, et al. Methicillinresistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 1994; 13: 50-55.
7. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005; 352: 1436-1444.
8. Centers for Disease Control and Prevention. Staphylococcus aureus resistant to vancomycin-United States, 2002. Mob Mortal Wkly Rep 2002; 51: 565-567.
9. Hiramatsu K, Hanaki H, Ino T, et al. A methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40: 135-146.
10. Smith TL, Pearson ML, Wilcox KR, et al. Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med 1990; 340: 493-501.
11. Rybak MJ, Hershberger E, Moldvan T, et al. In vitro activities of daptomycin, vancomycin, linezolid, and quinupristindalfopristin against staphylococci and enterococci, including vancomycin-intermediate and -resistant strains. Antimicrob Agents Chemother 2000; 44: 1062-1066.
12. Sawai T, Tomono K, Yanagihara K, et al. Role of coagulase in a murine model of hematogenous pulmonary infection by intravenous injection of Staphylococcus aureus enmeshed in agar beads. Infect Immun 1997; 65: 466-471.
13. Yanagihara K, Kaneko Y, Sawai T, et al. Efficacy of linezolid against methicillin-resistant or vancomycin-insensitive Staphylococcus aureus in a model of hematogenous pulmonary infection. Antimicrob Agents Chemother 2002; 46: 3288-3291.
14. Kaneko Y, Yanagihara K, Miyazaki Y, et al. Effects of DQ-113, a new quinolone, against methicillin- and vancomycin-resistant Staphylococcus aureus-caused hematogenous pulmonary infections in mice. Antimicrob Agents Chemother 2003; 47: 3694-3698.
15. Yanagihara K, Okada M, Fukuda Y, et al. Efficacy of quinpristindalfopristin against methicillin-resistant Staphylococcus aureus and vancomycin-insensitive S. aureus in a model of hematogenuos pulmonary infection. Chemotherapy 2004; 50: 260-264.
16. Yanagihara K, Seki M, Izumikawa K, et al. Potency of DX-619, a novel des-F(6)-quinolone, in haematogenous murine bronchopneumonia caused by methicillin-resistant and vancomycinintermediate Staphylococcus aureus. International J Antimicrob Agents 2006; 28: 212-216.
17. Yanagihara K, Tashiro M, Fukuda Y, et al. Effects of short interfering RNA against methicillin-resistant Staphylococcus aureus coagulase in vitro and in vivo. J Antimicrob Chemotherapy 2006; 57: 122-126.
18. Kimura K, Miyazaki S, Tateda K, et al. Factors affecting the course and severity of transnasally induced Staphylococcus aureus pneumonia in mice. J Med Microbiol 1999; 48: 1005-1010.
19. Bubeck Wardenburg J, Patel RJ, Schneewind O. Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia. Infect Immun 2007; 75: 1040-1044.
20. Bubeck Wardenburg J, Schneewind O. Vaccine protection against Staphylococcus aureus pneumonia. J Experimental Med 2008; 205: 287-294.
21. McElroy MC, Harty HR, Hosford GE, et al. Alpha-toxin damages the air-blood barrier of the lung in a rat model of Staphylococcus aureus-induced pneumonia. Infect Immun 1999; 67: 5541-5544.
22. Enkhbaatar P, Joncam C, Traber L, et al. Novel ovine model of methicillin-resistant Staphylococcus aureus-induced pneumonia and sepsis. Shock 2008; 29: 642-649.
23. Sibila O, Martinez-Olondris P, Agustí C, et al. An experimental model of pneumonia induced by MRSA in ventilated piglets. Am J Respir Crit Care Med 2007; 175: A327.
24. Tsiodras S, Gold HS, Sakoulas G, et al. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 2001; 358: 207-208.
25. Reyes N, Skinner R, Benton BM, et al. Efficacy of telavancin in a murine model of bacteraemia induced by methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 2006; 58: 462-465.